ALFA FinderBSE filing, BSE: 518053. Summary written from the filing by ALFA Finder's alert engine.
Sri Chakra Cement Ltd: key numbers
- Share price
- ₹31.20
- Market cap
- ₹28.08 Cr
- Revenue (annual)
- ₹128.6 Cr
- Net profit (annual)
- ₹-23.09 Cr
- P/E (TTM)
- -1.7×Sector 33.5×
- Promoter holding
- 51.61%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sri Chakra Cement Ltd
All →Sri Chakra Cement Q2 FY27 Results: Net Loss of ₹5.6 Cr, Loss Widens
Sri Chakra Cement Ltd reported a net loss of ₹5.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹5.6 Cr
Sri Chakra Cement Merger & Restructuring
Sri Chakra Cement's board approved sale of a 26% stake in Sri Subramanya Solar Power Projects LLP. It also approved unaudited quarterly results and an office relocation.
Sri Chakra Cement Board Meeting Date
Sri Chakra Cement Ltd will hold a board meeting on 12 November 2026 to approve unaudited financial results for the quarter and half-year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results are announced.
Sri Chakra Cement Other Announcement
Sri Chakra Cement Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance norms.
Sri Chakra Cement Management Change
Mr. Sriram Kapilavai has resigned as Whole-time Director of Sri Chakra Cement Limited, effective August 25, 2026. The company has formally disclosed this resignation.
Sri Chakra Cement Annual General Meeting
Sri Chakra Cement Limited held its 44th Annual General Meeting on August 19, 2026. The company discussed various agenda items, including the adoption of financial statements.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr